Vertex Pharmaceuticals Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$3,333,900	$2,986,900	$3,227,100	$3,076,400
Gross Profit	2,844,700	2,594,100	2,761,100	2,661,600
EBITDA	1,392,200	1,308,800	1,387,400	1,356,100
EBIT	1,391,799	1,252,900	1,334,300	1,302,100
Net Income	1,099,800	1,031,400	1,191,100	1,082,900
Net Change In Cash	3,333,900	2,986,900	3,227,100	3,076,400
Free Cash Flow	1,013,200	1,294,700	348,600	1,139,600
Cash	6,143,500	5,492,900	5,087,800	4,939,600
Basic Shares	255,700	256,300	256,100	257,600

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$12,074,600	$11,020,100	$9,869,200	$8,930,700
Gross Profit	10,267,500	9,489,600	8,607,000	7,850,400
EBITDA	4,863,700	486,300	4,605,200	4,435,500
EBIT	4,656,500	280,500	4,423,900	4,287,200
Net Income	3,953,200	-535,600	3,619,600	3,322,000
Net Change In Cash	12,074,600	11,020,100	9,869,200	8,930,700
Cost of Revenue				3,741,100
Free Cash Flow	3,193,800	-790,300	3,278,900	3,925,200
Cash	5,087,800	4,569,600	10,369,100	10,504,000
Basic Shares	258,000	257,900	260,500	259,100